Advertisement
Home 2015 September

Monthly Archives: September 2015

Cannabidiol from marijuana might help prevent epilepsy seizures

Cannabidiol May Help in the Treatment of Epilepsy

0
However, research is hindered by laws that limit access to marijuana
For adults with birch pollen-induced allergic rhinitis

Sublingual Birch Pollen Preparation Improves Allergy

0
Improvement in symptom scores for all treatment groups, with best response for highest dose
Various dermatological adverse events may occur after acupuncture

Various Dermatoses May Occur After Acupuncture

0
Most common adverse event is infectious skin disease, such as atypical mycobacterial infection
For adults with severe anorexia nervosa

Elevated Liver Enzymes Common in Severe Anorexia Nervosa

0
Elevated AST, ALT linked to lower BMI, development of hypoglycemia, hypophosphatemia
The total population of actively licensed physicians in the United States and the District of Columbia has increased by 4 percent since 2012

4% Increase in Population of Actively Licensed Physicians

0
Total population up to 916,264 in 2014; 12,168 more physicians being added annually than lost
For patients with relapsed or refractory hairy-cell leukemia

Vemurafenib Deemed Highly Effective in Hairy-Cell Leukemia

0
Findings from two phase 2 studies in Italy and United States show short oral course is highly effective
In the context of conventional cardiovascular disease (CVD) risk factors

Modest Predictive Power for HbA1c in Atherosclerotic CVD Risk

0
Incorporation of expected HbA1c distribution has modest effect on post-test atherosclerotic CVD risk
An online educational program aims to help physicians get back to work and reduce the nation's physician shortage

Physician Re-Entry Program Set to Redress Physician Shortage

0
Program open to physicians of any specialty who complete an intensive online curriculum
Two newly approved medications to treat high cholesterol are extremely overpriced compared to the health benefits they give to patients

ICER: New Cholesterol Drugs Highly Overpriced

0
Newly FDA-approved Repatha and Praluent currently cost more than $14,000 per year
Patients with delirium following major surgery are more likely to have worse outcomes

Post-Op Delirium Diminishes Recovery in Older Patients

0
Worse outcomes include increased hospital length of stay, disability, and mortality